Guillaume L. Martin

Guillaume L. Martin has extensive work experience in various healthcare-related roles. Guillaume L. began their career as a Medical Student Intern at Hospices Civils de Lyon in 2014. After that, they worked as a Medical Student Intern at Synapse Medicine in 2018, where they gained experience in clinical evaluation, regulation, and medical data annotation.

In 2018, Martin continued their work at Synapse Medicine as a Consultant Medical Project Manager, using their scientific expertise to support clinical studies and integrate medical data databases. Guillaume L. also provided medical regulatory support and was a main speaker at a conference in 2022.

During their time as an MD Resident and Medical Project Manager at Synapse Medicine from 2020 to 2021, Martin developed AI medical intelligence tools and NLP-based declaration tools for pharmacovigilance. Guillaume L. managed different projects and provided medical operations support for both back-end and front-end teams.

In 2019, Martin served as President of Les Ateliers Mercure, a healthcare thinktank focused on exploring pragmatic and evidence-based solutions to improve the healthcare system.

In 2020, Martin had two roles, one as an MD Resident in Crisis Communication at the French Ministry of Health, where they handled COVID-19 medical and scientific communication and managed the communication team. The other role was as an MD Resident in Disease Prevention and Control.

From 2019 to 2020, Martin worked as an MD Resident in Market Access at Eli Lilly and Company, where they developed drug market access strategies and pricing and reimbursement strategies in various therapeutic fields.

In 2020, Martin also had a rotation at Cnam, France's healthcare single payer agency, as an MD Resident in the Direction for Strategy, Studies, and Statistics. Guillaume L. conducted an epidemiological study using a nationwide medico-administrative database and studied patient care pathways.

In 2021, Martin had a rotation at IQVIA as an MD Resident in Real World Evidence, supporting clinical and observational research projects for clients.

Lastly, Martin is currently working at Greater Paris University Hospitals - AP-HP as a Junior MD in Clinical Research and Pharmacoepidemiology. Guillaume L. is involved in their PhD work, methodological support, tenders submission, data analysis, and multidisciplinary interactions.

Guillaume L. Martin has a diverse educational background with a focus on healthcare and data science. Guillaume L. obtained their BFC (Business Administration and Management) degree from INSEAD in 2022. Guillaume L. is currently pursuing a PhD in Epidemiology and Data-science from Sorbonne Université, a program they started in 2021 and is expected to complete in 2024.

Prior to their PhD, Guillaume completed their Medical Degree with a specialization in Public Health from Université Paris-Saclay. Guillaume L.'sdegree duration was from 2018 to 2023. Additionally, they obtained an MSc in Clinical Research and RWD/RWE from Sorbonne Université in 2021.

Earlier in their education, Guillaume attained an MPH (Master of Public Health) degree from Université Paris-Saclay for the duration of 2018-2019. Guillaume L. began their academic journey at Université Claude Bernard Lyon 1, where they earned their Undergrad MD degree from 2012 to 2018. During the same period, they also completed a Master 1 in Biochemistry / Biotechnologies / Health economics from the same institution.

In terms of certifications, Guillaume became a Peer Reviewer for Elsevier in June 2022. Guillaume L. also holds a Certificate in Advanced English (grade A) - C2 level from Cambridge Assessment, which they obtained in 2012.